Lashinger LM - Search Results

1

Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.

Metwalli AR, Khanbolooki S, Jinesh G, Sundi D, Shah JB, Shrader M, Choi W, Lashinger LM, Chunduru S, McConkey DJ, McKinlay M, Kamat AM. Metwalli AR, et al. Among authors: lashinger lm. Cancer Biol Ther. 2010 Nov 1;10(9):885-92. doi: 10.4161/cbt.10.9.13237. Epub 2010 Nov 1. Cancer Biol Ther. 2010. PMID: 20814238 Free PMC article.

2

Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.

Raut CP, Nawrocki S, Lashinger LM, Davis DW, Khanbolooki S, Xiong H, Ellis LM, McConkey DJ. Raut CP, et al. Among authors: lashinger lm. Cancer Biol Ther. 2004 Dec;3(12):1217-24. doi: 10.4161/cbt.3.12.1221. Epub 2004 Dec 9. Cancer Biol Ther. 2004. PMID: 15477758

3

Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells.

Lashinger LM, Zhu K, Williams SA, Shrader M, Dinney CP, McConkey DJ. Lashinger LM, et al. Cancer Res. 2005 Jun 1;65(11):4902-8. doi: 10.1158/0008-5472.CAN-04-3701. Cancer Res. 2005. PMID: 15930312

4

Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells.

Papageorgiou A, Lashinger L, Millikan R, Grossman HB, Benedict W, Dinney CP, McConkey DJ. Papageorgiou A, et al. Cancer Res. 2004 Dec 15;64(24):8973-9. doi: 10.1158/0008-5472.CAN-04-1909. Cancer Res. 2004. PMID: 15604261

5

Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.

Shrader M, Pino MS, Lashinger L, Bar-Eli M, Adam L, Dinney CP, McConkey DJ. Shrader M, et al. Cancer Res. 2007 Feb 15;67(4):1430-5. doi: 10.1158/0008-5472.CAN-06-1224. Cancer Res. 2007. PMID: 17308080

6

The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo.

Kamat AM, Karashima T, Davis DW, Lashinger L, Bar-Eli M, Millikan R, Shen Y, Dinney CP, McConkey DJ. Kamat AM, et al. Mol Cancer Ther. 2004 Mar;3(3):279-90. Mol Cancer Ther. 2004. PMID: 15026548

7

Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight mice.

Liu KA, Lashinger LM, Rasmussen AJ, Hursting SD. Liu KA, et al. Among authors: lashinger lm. Cancer Metab. 2014 Mar 31;2(1):6. doi: 10.1186/2049-3002-2-6. Cancer Metab. 2014. PMID: 24685128 Free PMC article.

8

Starving cancer from the outside and inside: separate and combined effects of calorie restriction and autophagy inhibition on Ras-driven tumors.

Lashinger LM, O'Flanagan CH, Dunlap SM, Rasmussen AJ, Sweeney S, Guo JY, Lodi A, Tiziani S, White E, Hursting SD. Lashinger LM, et al. Cancer Metab. 2016 Sep 16;4:18. doi: 10.1186/s40170-016-0158-4. eCollection 2016. Cancer Metab. 2016. PMID: 27651895 Free PMC article.

9

Obesity and resistance to cancer chemotherapy: interacting roles of inflammation and metabolic dysregulation.

Lashinger LM, Rossi EL, Hursting SD. Lashinger LM, et al. Clin Pharmacol Ther. 2014 Oct;96(4):458-63. doi: 10.1038/clpt.2014.136. Epub 2014 Jun 24. Clin Pharmacol Ther. 2014. PMID: 24960521 Review.

10

Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer.

Lashinger LM, Malone LM, Brown GW, Daniels EA, Goldberg JA, Otto G, Fischer SM, Hursting SD. Lashinger LM, et al. Cancer Prev Res (Phila). 2011 Jul;4(7):1041-51. doi: 10.1158/1940-6207.CAPR-11-0023. Epub 2011 May 18. Cancer Prev Res (Phila). 2011. PMID: 21593197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters